Impact of a natural disaster on access to care and biopsychosocial outcomes among Hispanic/Latino cancer survivors
Impact of a natural disaster on access to care and biopsychosocial outcomes among Hispanic/Latino cancer survivors
Blog Article
Abstract Cancer is the leading cause of death in Puerto Rico (PR).Hurricane Maria (HM) and its aftermath lead to widespread devastation on the island, including the collapse of the healthcare system.Medically fragile populations, such as cancer survivors, were significantly affected.The goal of this study was to assess the impact of HM on CHAMOMILE SHAMPOO barriers to care, emotional distress, and inflammatory biomarkers among cancer survivors in PR.This exploratory longitudinal study was conducted in health care facilities and community support groups from PR.
Cancer survivors (n = 50) and non-cancer participants (n = 50) completed psychosocial questionnaires and provided blood samples that were used to assess inflammatory cytokines levels.Among this cohort, we identified 41 matched cancer survivors/non-cancer participants pairs.Data were analyzed through descriptive, frequencies, correlational, and regression analyses.Cancer survivors that were affected by HM reported increased barriers in accessing medical care, which were directly associated with anxiety, perceived stress, and post-traumatic symptomatology.Moreover, being a cancer survivor, predicted more barriers to receiving health care, especially in the first six weeks after the event, after which the effect was attenuated.
Several inflammatory cytokines, such as CD31, BDNF, TFF3, Serpin E-1, VCAM-1, Vitamin D BP, and PDGF-AA, were significantly upregulated in cancer survivors while MMP9 and Osteopontin both had significant positive correlations Fixed Blade Tactical with barriers to care.HM significantly impacted Puerto Ricans psychosocial well-being.Cancer survivors had significant barriers to care and showed increased serum inflammatory cytokines but did not show differences in anxiety, stress, and post-traumatic symptoms compared to non-cancer participants.